About Guardant Health
Guardant Health develops liquid biopsy tests using cell-free DNA analysis for early cancer detection, therapy selection, and treatment monitoring, enabling minimally invasive precision oncology testing.
Structured data
Type:MedicalBusiness
Area:United States, Europe, Global
Hours:Mo-Fr 08:00-18:00
Knows about
Liquid BiopsyCell-Free DNAEarly Cancer DetectionTherapy SelectionMinimal Residual DiseaseShield Colorectal Test